These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19845233)

  • 1. Protection of radiocontrast induced nephropathy by vitamin E (alpha tocopherol): a randomized controlled pilot study.
    Tasanarong A; Piyayotai D; Thitiarchakul S
    J Med Assoc Thai; 2009 Oct; 92(10):1273-81. PubMed ID: 19845233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
    Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
    Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
    Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
    Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
    Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
    Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
    J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
    Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
    Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
    Morikawa S; Sone T; Tsuboi H; Mukawa H; Morishima I; Uesugi M; Morita Y; Numaguchi Y; Okumura K; Murohara T
    J Am Coll Cardiol; 2009 Mar; 53(12):1040-6. PubMed ID: 19298916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of alpha tocopherol on contrast-induced nephropathy in rats.
    Kongkham S; Sriwong S; Tasanarong A
    Nefrologia; 2013 Jan; 33(1):116-23. PubMed ID: 23364634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
    Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.